Dry AMD and Geographic Atrophy 2022
Podcasts
Podcasts
Part 1
Dry AMD & Geographic Atrophy
In this episode of the EURETINA IME podcast series on dry AMD and GA Prof Frank G. Holz (Germany) and Prof Adnan Tufail (UK) discuss key considerations in early diagnosis, including some tricky subjects like defining the meaning of “dry” AMD, why early diagnosis is so important, the imaging modalities they use and biomarkers they are looking for. Thanks to Apellis and Roche for their support of this EURETINA Independent Medical Education podcast.
Podcasts
Part 2
Dry AMD & Geographic Atrophy
In this episode of the EURETINA IME podcast series on dry AMD and GA Prof Frank G. Holz (Germany) and Prof Adnan Tufail (UK) discuss emerging treatment options for geographic atrophy including the role of the complement system, how emerging treatments inhibit this pathway to influence disease progression, treatment administration and frequency, as well as patient selection. They also cover other promising treatment approaches, discussing these with patients, and how we evaluate our outcomes between structural and functional endpoints. Thanks to Apellis and Roche for their support of this EURETINA Independent Medical Education podcast.
eLearning
Emerging Treatment Options For Geographic Atrophy: A Focus on Complement-Based Therapies
Jeffrey Heier, MD
In this independent medical education eLearning module (support provided by Roche and Apellis), Dr Jeffrey Heier MD (Ophthalmic Consultants of Boston) will outline what complement therapies are, how they work and report on some of the recent trials. He will also outline some other new approaches to treatment options.
Supplements
Independent medical education support provided by
Apellis | Roche